87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Research reveals how fructose in diet enhances tumor growth

Research reveals how fructose in diet enhances tumor growth

byWashington University in St. LouisCredit: CC0 Public DomainFructose consumption has increased considerably over the past five decades, largely due to the widespread use of high-fructose corn s

Research reveals how fructose in diet enhances tumor growth

byWashington University in St. LouisCredit: CC0 Public DomainFructose consumption has increased considerably over the past five decades, largely due to the widespread use of high-fructose corn s
Innovative red blood cell shape test promises better blood storage and transfusions

Innovative red blood cell shape test promises better blood storage and transfusions

Innovative red blood cell shape test promises better blood storage and transfusionsbyUniversity of OxfordCredit: Pixabay/CC0 Public DomainScientists have developed a way of assessing the ability

Innovative red blood cell shape test promises better blood storage and transfusions

Innovative red blood cell shape test promises better blood storage and transfusionsbyUniversity of OxfordCredit: Pixabay/CC0 Public DomainScientists have developed a way of assessing the ability
Annual report reveals more cancers are being treated with personalized therapies before surgery

Annual report reveals more cancers are being treated with personalized therapies before surgery

byAmerican College of SurgeonsWhat to know about breast cancer according to the National Cancer Database. Credit: American College of SurgeonsBreast, bladder, and pancreatic cancers are increasi

Annual report reveals more cancers are being treated with personalized therapies before surgery

byAmerican College of SurgeonsWhat to know about breast cancer according to the National Cancer Database. Credit: American College of SurgeonsBreast, bladder, and pancreatic cancers are increasi
Machine learning uncovers three osteosarcoma subtypes for targeted treatment

Machine learning uncovers three osteosarcoma subtypes for targeted treatment

byUniversity of East AngliaLatent process decomposition model optimization, subtype assignment and clinical outcome. Credit:Briefings in Bioinformatics(2024). DOI: 10.1093/bib/bbae66

Machine learning uncovers three osteosarcoma subtypes for targeted treatment

byUniversity of East AngliaLatent process decomposition model optimization, subtype assignment and clinical outcome. Credit:Briefings in Bioinformatics(2024). DOI: 10.1093/bib/bbae66
Oncologist discusses treating liver cancer

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver
Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi
Low-dose plasma treatment shows promise for slowing down tumor growth

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t
Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while
Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi
Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1